Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy

David B. Hanna, Molly Jung, Xiaonan (Nan) Xue, Kathryn Anastos, Jennifer M. Cocohoba, Mardge H. Cohen, Elizabeth T. Golub, Nancy A. Hessol, Alexandra M. Levine, Tracey E. Wilson, Mary A. Young, Robert C. Kaplan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure <140/90 mmHg), diabetes treatment and control (fasting glucose <130 mg/dL), and smoking quit rates in the Women's Interagency HIV Study. Unadjusted and adjusted Poisson regression models tested time trends and differences between HIV+ and HIV- women. Among antiretroviral therapy (ART) users, we examined the association of ART adherence and virologic suppression with each outcome. We evaluated 1636 HIV+ and 683 HIV- women, with a hypertension prevalence of 40% and 38%, respectively; diabetes prevalence of 21% and 22%; and smoking prevalence of 37% and 48%. Hypertension treatment was higher among HIV+ than HIV- women (77% vs. 67%, p < 0.001) and increased over time with no difference in trend by HIV status. Hypertension control was greater among HIV+ women (56% vs. 43%, p < 0.001) and increased over time among HIV+ but not HIV- women. Diabetes treatment was similar among HIV+ and HIV- women (48% vs. 49%) and increased over time in both groups. Diabetes control was greater among HIV+ women (73% vs. 64%, p = 0.03) and did not change over time. The percent of recent smokers who reported no longer smoking was similar between HIV+ and HIV- women (10% vs. 9%), with no differences over time. Virologic suppression was significantly associated with increased hypertension treatment and greater control. HIV+ women have better control of hypertension and diabetes than HIV- women, but many are still not at target levels.

Original languageEnglish (US)
Pages (from-to)445-454
Number of pages10
JournalAIDS Patient Care and STDs
Volume30
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Risk Management
Cardiovascular Diseases
HIV
Therapeutics
Hypertension
Smoking

Keywords

  • antiretroviral therapy
  • cardiovascular disease
  • diabetes mellitus
  • HIV-1 viral load
  • hypertension
  • smoking

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy. / Hanna, David B.; Jung, Molly; Xue, Xiaonan (Nan); Anastos, Kathryn; Cocohoba, Jennifer M.; Cohen, Mardge H.; Golub, Elizabeth T.; Hessol, Nancy A.; Levine, Alexandra M.; Wilson, Tracey E.; Young, Mary A.; Kaplan, Robert C.

In: AIDS Patient Care and STDs, Vol. 30, No. 10, 01.10.2016, p. 445-454.

Research output: Contribution to journalArticle

Hanna, David B. ; Jung, Molly ; Xue, Xiaonan (Nan) ; Anastos, Kathryn ; Cocohoba, Jennifer M. ; Cohen, Mardge H. ; Golub, Elizabeth T. ; Hessol, Nancy A. ; Levine, Alexandra M. ; Wilson, Tracey E. ; Young, Mary A. ; Kaplan, Robert C. / Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy. In: AIDS Patient Care and STDs. 2016 ; Vol. 30, No. 10. pp. 445-454.
@article{a886cc5500904839a8ace3bd77155b43,
title = "Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy",
abstract = "Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure <140/90 mmHg), diabetes treatment and control (fasting glucose <130 mg/dL), and smoking quit rates in the Women's Interagency HIV Study. Unadjusted and adjusted Poisson regression models tested time trends and differences between HIV+ and HIV- women. Among antiretroviral therapy (ART) users, we examined the association of ART adherence and virologic suppression with each outcome. We evaluated 1636 HIV+ and 683 HIV- women, with a hypertension prevalence of 40{\%} and 38{\%}, respectively; diabetes prevalence of 21{\%} and 22{\%}; and smoking prevalence of 37{\%} and 48{\%}. Hypertension treatment was higher among HIV+ than HIV- women (77{\%} vs. 67{\%}, p < 0.001) and increased over time with no difference in trend by HIV status. Hypertension control was greater among HIV+ women (56{\%} vs. 43{\%}, p < 0.001) and increased over time among HIV+ but not HIV- women. Diabetes treatment was similar among HIV+ and HIV- women (48{\%} vs. 49{\%}) and increased over time in both groups. Diabetes control was greater among HIV+ women (73{\%} vs. 64{\%}, p = 0.03) and did not change over time. The percent of recent smokers who reported no longer smoking was similar between HIV+ and HIV- women (10{\%} vs. 9{\%}), with no differences over time. Virologic suppression was significantly associated with increased hypertension treatment and greater control. HIV+ women have better control of hypertension and diabetes than HIV- women, but many are still not at target levels.",
keywords = "antiretroviral therapy, cardiovascular disease, diabetes mellitus, HIV-1 viral load, hypertension, smoking",
author = "Hanna, {David B.} and Molly Jung and Xue, {Xiaonan (Nan)} and Kathryn Anastos and Cocohoba, {Jennifer M.} and Cohen, {Mardge H.} and Golub, {Elizabeth T.} and Hessol, {Nancy A.} and Levine, {Alexandra M.} and Wilson, {Tracey E.} and Young, {Mary A.} and Kaplan, {Robert C.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1089/apc.2016.0143",
language = "English (US)",
volume = "30",
pages = "445--454",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy

AU - Hanna, David B.

AU - Jung, Molly

AU - Xue, Xiaonan (Nan)

AU - Anastos, Kathryn

AU - Cocohoba, Jennifer M.

AU - Cohen, Mardge H.

AU - Golub, Elizabeth T.

AU - Hessol, Nancy A.

AU - Levine, Alexandra M.

AU - Wilson, Tracey E.

AU - Young, Mary A.

AU - Kaplan, Robert C.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure <140/90 mmHg), diabetes treatment and control (fasting glucose <130 mg/dL), and smoking quit rates in the Women's Interagency HIV Study. Unadjusted and adjusted Poisson regression models tested time trends and differences between HIV+ and HIV- women. Among antiretroviral therapy (ART) users, we examined the association of ART adherence and virologic suppression with each outcome. We evaluated 1636 HIV+ and 683 HIV- women, with a hypertension prevalence of 40% and 38%, respectively; diabetes prevalence of 21% and 22%; and smoking prevalence of 37% and 48%. Hypertension treatment was higher among HIV+ than HIV- women (77% vs. 67%, p < 0.001) and increased over time with no difference in trend by HIV status. Hypertension control was greater among HIV+ women (56% vs. 43%, p < 0.001) and increased over time among HIV+ but not HIV- women. Diabetes treatment was similar among HIV+ and HIV- women (48% vs. 49%) and increased over time in both groups. Diabetes control was greater among HIV+ women (73% vs. 64%, p = 0.03) and did not change over time. The percent of recent smokers who reported no longer smoking was similar between HIV+ and HIV- women (10% vs. 9%), with no differences over time. Virologic suppression was significantly associated with increased hypertension treatment and greater control. HIV+ women have better control of hypertension and diabetes than HIV- women, but many are still not at target levels.

AB - Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure <140/90 mmHg), diabetes treatment and control (fasting glucose <130 mg/dL), and smoking quit rates in the Women's Interagency HIV Study. Unadjusted and adjusted Poisson regression models tested time trends and differences between HIV+ and HIV- women. Among antiretroviral therapy (ART) users, we examined the association of ART adherence and virologic suppression with each outcome. We evaluated 1636 HIV+ and 683 HIV- women, with a hypertension prevalence of 40% and 38%, respectively; diabetes prevalence of 21% and 22%; and smoking prevalence of 37% and 48%. Hypertension treatment was higher among HIV+ than HIV- women (77% vs. 67%, p < 0.001) and increased over time with no difference in trend by HIV status. Hypertension control was greater among HIV+ women (56% vs. 43%, p < 0.001) and increased over time among HIV+ but not HIV- women. Diabetes treatment was similar among HIV+ and HIV- women (48% vs. 49%) and increased over time in both groups. Diabetes control was greater among HIV+ women (73% vs. 64%, p = 0.03) and did not change over time. The percent of recent smokers who reported no longer smoking was similar between HIV+ and HIV- women (10% vs. 9%), with no differences over time. Virologic suppression was significantly associated with increased hypertension treatment and greater control. HIV+ women have better control of hypertension and diabetes than HIV- women, but many are still not at target levels.

KW - antiretroviral therapy

KW - cardiovascular disease

KW - diabetes mellitus

KW - HIV-1 viral load

KW - hypertension

KW - smoking

UR - http://www.scopus.com/inward/record.url?scp=84992036356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992036356&partnerID=8YFLogxK

U2 - 10.1089/apc.2016.0143

DO - 10.1089/apc.2016.0143

M3 - Article

C2 - 27749112

AN - SCOPUS:84992036356

VL - 30

SP - 445

EP - 454

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 10

ER -